๊ธ๋ฆฌ์ฝํผ๋ก๋ / ๊ธ๋ฆฌ์ฝํผ๋กค๋ ์ดํธ
**๊ธ๋ฆฌ์ฝํผ๋ก๋**(๋๋ **๊ธ๋ฆฌ์ฝํผ๋กค๋ ์ดํธ**)์ ๊ฐ๋ ฅํ ํญ์ฝ๋ฆฐ์ ๋ฐ ํญํ์ก๋ถ๋น์ ์ ๋๋ค. ์์ ๋ง์ทจ์์ ์ฃผ๋ก ๊ตฌ๊ฐ ๋ฐ ๊ธฐ๊ด์ง ๋ถ๋น๋ฌผ์ ๊ฐ์์ํค๊ณ , ๋ฏธ์ฃผ์ ๊ฒฝ ์์ฌ์ฑ ํ๋์ ์ต์ ํ๋ฉฐ, ๊ฐ๋ ฅํ ์คํผ์ค์ด๋ ์ฝ๋ฌผ ํฌ์ฌ๋ก ์ธํ ์๋งฅ์ ๊ด๋ฆฌํ๋ ๋ฐ ์ฌ์ฉ๋ฉ๋๋ค. ๋ํ ์ ๊ฒฝ๊ทผ ์ฐจ๋จ ๊ธธํญ ์ ์ง์์ฑ ํญ์ฝ๋ฆฐ์์คํ ๋ผ์ (์: ๋ค์ค์คํฐ๊ทธ๋ฏผ)์ ํจ๊ป ์ฌ์ฉ๋ฉ๋๋ค. > **์์ ๊ฒฝ๊ณ :** ๋ง์ทจ ์ ํฌ์ฝ์ ์ผํ์ผ๋ก ๊ธ๋ฆฌ์ฝํผ๋ก๋์ ์ผ์์ ์ผ๋ก ํฌ์ฌํ๋ ๊ฒ์ ๋ ์ด์ ๊ถ์ฅ๋์ง ์์ต๋๋ค. ๋ถ๋น๋ฌผ์ ์๋ถ ํจ๋์ ๊ฐ์์์ผ ๊ธฐ๋ ๋ถ๋น๋ฌผ์ ๋ ๋์ ํ๊ฒ ๋ง๋ค๊ณ ๋ฐฐ์ถํ๊ธฐ ์ด๋ ต๊ฒ ํ๊ธฐ ๋๋ฌธ์ ๋๋ค.
์์ฉ ๊ธฐ์ : Competitively blocks the action of **acetylcholine** at **muscarinic receptors** at the terminal ends of the parasympathetic nervous system โ reverses parasympathetic effects (e.g., increases heart rate, reduces salivation). **Clinical Pearl:** Because of its quaternary ammonium structure, glycopyrronium cannot cross the blood-brain barrier. Therefore, it is devoid of central nervous system effects and does not cause central mydriasis, unlike atropine. It also has a longer duration of action compared to atropine.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Concurrent use with alpha-2 adrenergic agonists is not recommended
์ด์๋ฐ์
- Tachycardia
- Ventricular arrhythmias
- Thickened, sticky airway secretions
- Paradoxical bradycardia (at very low IV doses)
์ฝ๋ฌผ ์ํธ์์ฉ
- Barbiturates (alkaline drugs) ยท In vitro incompatibility; a precipitate may form if mixed together ยท major
- Sympathomimetics ยท Antimuscarinics may enhance the actions of sympathomimetics ยท moderate
- Thiazide diuretics ยท Antimuscarinics may enhance the actions of thiazide diuretics ยท moderate
- Antihistamines ยท May enhance the anticholinergic activity of glycopyrronium ยท moderate
- Pethidine ยท May enhance the anticholinergic activity of glycopyrronium ยท moderate
- Benzodiazepines ยท May enhance the anticholinergic activity of glycopyrronium ยท moderate
- Phenothiazines ยท May enhance the anticholinergic activity of glycopyrronium ยท moderate
- Alpha-2 adrenergic agonists ยท Combining glycopyrronium and alpha-2 adrenergic agonists is not recommended due to conflicting cardiovascular effects ยท major
๋ชจ๋ํฐ๋ง
- Heart rate and rhythm (ECG)
- Respiratory rate and airway patency
๊ณผ์ฉ๋
Tachycardias following an overdose of glycopyrronium are usually transient and do not require management. If severe ventricular arrhythmias occur, they may be treated with **lidocaine**.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.